NAD+ levels fall up to 65% as we age. Learn the clinical science behind Niagen Bioscience's NAD precursor and how it fights ...
As America approaches its 250th anniversary, the companies will pursue the development of scalable seedling technologies to support the first-ever restoration of a native tree species from functional ...
First consumer health product positions Daré for revenue generation while expanding its women's health leadership platform ...
Satellos Bioscience's shares jumped Monday after the Duchenne treatment being developed by the biotechnology company received fast track designation in the U.S. In morning trading, the shares rose 12% ...
Discover the science of NAD+ and how it impacts your healthspan. Watch Mona Rosene explain cellular repair and how to fight ...
Your biotech fund just posted a big gain, but the reason why is more about the whole sector than any single star.
Interior Department is partnering with Colossal Biosciences to create a genetic archive for endangered species.
SAT-3247 has now received FDA Fast Track, Orphan Drug and Rare Pediatric Disease designations for Duchenne muscular dystrophy ("Duchenne" or "DMD")Fast Track is designed to expedite the development/re ...
The dosage information for drugs used in HIV treatment, malaria, cancer care, pain management and transplantation is largely ...
The National Vaccine Institute (NVI), the Government Pharmaceutical Organisation (GPO) and the Department of Disease Control ...
As Dhaka University enters its 106th year, the country's premier institution is pursuing an ambitious vision of becoming a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results